AI-driven decision engines and intelligent orchestration layers are crucial for navigating geopolitical risks and manufacturing inefficiencies in the pharmaceutical sector. Digital twins and unified ...

From the moment we could look up to the skies, humanity has dreamt of what’s up there. And once we got there, how could we master it? And now that we’re there all the time, how can we use it? In 2025, ...

A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.

Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the pharmaceutical industry's impact on healthcare.

After several notable moves to grow the reach of its biomanufacturing platform in recent months, Antheia is linking arms with a pharmaceutical ingredient juggernaut in this field. Antheia is teaming ...

AstraZeneca's MFN pricing agreement with the US government reflects broader efforts to reduce drug prices and enhance ...

Throughout 2025, drugmakers of all stripes have collectively poured billions of dollars into U.S. manufacturing investments. Many of those projects have centered on later stages of the production ...

President Donald Trump announced a new round of tariffs beginning in October 2025 that would impose a 100% duty on brand name drugs imported to the United States. There's a major exemption to the ...